gera Therapeutics
Founded Year
2000Stage
Acquired | AcquiredTotal Raised
$12.3MAbout gera Therapeutics
Aegera Therapeutics, located in Montreal, Canada, is a business unit of Pharmascience focused on developing targeted therapeutics to address major unmet medical needs. Aegera focuses on preclinical and early-stage clinical development through integration of "in-house" medicinal chemistry, biochemistry, cell biology, pharmacokinetics and in vivo pharmacology/efficacy. Aegera has two oncology programs in clinical development. Aegera is also dedicated to identifying novel development candidates based upon its core technologies, internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.
Missing: gera Therapeutics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: gera Therapeutics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing gera Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
gera Therapeutics is included in 1 Expert Collection, including Cancer.
Cancer
1,179 items
Pharmaceutical and biotechnology companies with cancer therapy drug candidates.
gera Therapeutics Frequently Asked Questions (FAQ)
When was gera Therapeutics founded?
gera Therapeutics was founded in 2000.
What is gera Therapeutics's latest funding round?
gera Therapeutics's latest funding round is Acquired.
How much did gera Therapeutics raise?
gera Therapeutics raised a total of $12.3M.
Who are the investors of gera Therapeutics?
Investors of gera Therapeutics include Pharmascience, BDC Venture Capital, GrowthWorks, Multiple Capital, Fondaction and 12 more.
Who are gera Therapeutics's competitors?
Competitors of gera Therapeutics include BioCogent, Rotation Medical, Larimar Therapeutics, Regado Biosciences, Incline Therapeutics and 11 more.
Compare gera Therapeutics to Competitors
Alice Therapeutics is a biotechnology company.
Athersys develops biotechnology-based therapeutics.
REGiMMUNE is a biotechnology company focused on the discovery, development and commercialization of immune regulatory therapeutics to treat conditions such as allergies, autoimmune diseases and inflammatory disorders.
Raylab is a communication design company with expertise in the biotechnology industry
Catapult is a San Diego-based incubator for biomedical start-ups.
Aurora Biomed is a biotechnology company
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.